Gene · 8726
Papers3,114
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,114
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. | J Exp Clin Cancer Res | 2023 | 36717865 | PubTator, text mining | PubMed |
| BRPF1 bridges H3K4me3 and H3K23ac in human embryonic stem cells and is essential to pluripotency. | iScience | 2023 | 36711238 | PubTator, text mining | PubMed |
| Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia. | Asian Pac J Cancer Prev | 2023 | 36708555 | PubTator, text mining | PubMed |
| A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency. | PLoS Pathog | 2023 | 36706161 | PubTator, text mining | PubMed |
| Inhibition of EED activity enhances cell survival of female germline stem cell and improves the oocytes production during oogenesis in vitro. | Open Biol | 2023 | 36695089 | PubTator, text mining | PubMed |
| Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer. | Molecules | 2023 | 36677797 | PubTator, text mining | PubMed |
| Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management. | Int J Mol Sci | 2023 | 36674656 | PubTator, text mining | PubMed |
| EZH2: An Accomplice of Gastric Cancer. | Cancers (Basel) | 2023 | 36672374 | PubTator, text mining | PubMed |
| Deciphering Hierarchical Chromatin Domains and Preference of Genomic Position Forming Boundaries in Single Mouse Embryonic Stem Cells. | Adv Sci (Weinh) | 2023 | 36658736 | PubTator, text mining | PubMed |
| Epigenetic resetting in the human germ line entails histone modification remodeling. | Sci Adv | 2023 | 36652508 | PubTator, text mining | PubMed |
| Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder. | Clin Genet | 2023 | 36645289 | PubTator, text mining | PubMed |
| Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. | Signal Transduct Target Ther | 2023 | 36642705 | PubTator, text mining | PubMed |
| Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression. | Cold Spring Harb Mol Case Stud | 2023 | 36639200 | PubTator, text mining | PubMed |
| PRC2 disruption in cerebellar progenitors produces cerebellar hypoplasia and aberrant myoid differentiation without blocking medulloblastoma growth. | Acta Neuropathol Commun | 2023 | 36635771 | PubTator, text mining | PubMed |
| Polycomb repressive complexes 1 and 2 are each essential for maintenance of X inactivation in extra-embryonic lineages. | Nat Cell Biol | 2023 | 36635505 | PubTator, text mining | PubMed |
| Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes. | Nat Cell Biol | 2023 | 36635503 | PubTator, text mining | PubMed |
| A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia. | Blood Adv | 2023 | 36607839 | PubTator, text mining | PubMed |
| Intimate communications within the tumor microenvironment: stromal factors function as an orchestra. | J Biomed Sci | 2023 | 36600243 | PubTator, text mining | PubMed |
| Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Cancer Discov | 2023 | 36598417 | PubTator, text mining | PubMed |
| Role of primary aging hallmarks in Alzheimer´s disease. | Theranostics | 2023 | 36593969 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8726/papers?page=20